Rare diseases
Investigational molecules
Locations
Tuborg Boulevard 12, 2900 Hellerup, Denmark
Ascendis Pharma Growth Disorders A/S focuses its clinical research on achondroplasia across pediatric age groups, with studies centered on growth, linear growth, and the clinical needs of affected children and adolescents.
The sponsor’s research activity includes both younger and older pediatric populations, reflecting a sustained interest in the treatment of growth disorders associated with this condition.
Ascendis Pharma Growth Disorders A/S runs clinical trials in conditions such as Osteochondrodysplasia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Denmark
AustriaAustriaDenmarkDenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
